Literature DB >> 18379088

Study on the interactions of kaempferol and quercetin with intravenous immunoglobulin by fluorescence quenching, fourier transformation infrared spectroscopy and circular dichroism spectroscopy.

Yong-Chun Liu1, Zheng-Yin Yang, Juan Du, Xiao-Jun Yao, Rui-Xia Lei, Xu-Dong Zheng, Jian-Ning Liu, Huai-Sheng Hu, Hong Li.   

Abstract

The interactions of kaempferol and quercetin with intravenous immunoglobulin (IVIG) were studied in vitro by spectroscopic methods including fluorescence spectra, Fourier transformation infrared (FT-IR) spectra and circular dichroism (CD) spectra. The binding parameters for the reactions calculated according to the Sips equation suggested that the bindings of IVIG to kaempferol and quercetin were characterized by two binding sites with the average affinity constants K(o) at 1.032 x 10(4) M(-1) and 1.849 x 10(4) M(-1), respectively. The binding of IVIG with quercetin is stronger than that of IVIG with kaempferol. They were of non-specific and weak drug-protein interactions. Docking was used to calculate the interaction modes between kaempferol and quercetin with IVIG. The secondary structural compositions of free IVIG and its kaempferol, quercetin complexes were calculated by the FT-IR difference spectra, self-deconvolution, second derivative resolution enhancement and the curve-fitting procedures of amide I band respectively, which are in good agreement with the analyses of CD spectra. The effect of 3'-OH substituent in quercetin is distinct between the interactions of IVIG with kaempferol and quercetin for the secondary structure of the protein. The observed spectral changes indicate a partial unfolding of the protein structure, but the typical beta structural conformation of IVIG is still retentive in the presence of both drugs in aqueous solution. The average binding distances between the chromophores of IVIG with kaempferol (4.30 nm) and quercetin (4.35 nm) were obtained on the basis of the theory of Förster energy transfer. IVIG can serve as transport protein (carrier) for kaempferol and quercetin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379088     DOI: 10.1248/cpb.56.443

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  6 in total

1.  Fabrication of an electrochemical biosensor with ZnO nanoflakes interface for methylglyoxal quantification in food samples.

Authors:  Amudha Jayaprakasan; Amarnath Thangavel; Lakshmishri Ramachandra Bhat; Manju Bhargavi Gumpu; Noel Nesakumar; K Jayanth Babu; Srinivasan Vedantham; John Bosco Balaguru Rayappan
Journal:  Food Sci Biotechnol       Date:  2017-12-02       Impact factor: 2.391

2.  Carboxylate-dependent gelation of a monoclonal antibody.

Authors:  Osigwe Esue; Sonoko Kanai; Jun Liu; Thomas W Patapoff; Steven J Shire
Journal:  Pharm Res       Date:  2009-11       Impact factor: 4.200

3.  Sulfadiazine binds and unfolds bovine serum albumin: an in vitro study.

Authors:  Hamad A Al-Lohedan; Mohd Sajih Ali
Journal:  Mol Biol Rep       Date:  2013-11       Impact factor: 2.316

4.  2-(2-Hydroxy-5-nitrobenzylidene)-1,3-indanedione versus Fluorescein Isothiocyanate in Interaction with Anti-hFABP Immunoglobulin G1: Fluorescence Quenching, Secondary Structure Alteration and Binding Sites Localization.

Authors:  Dana Stan; Carmen-Marinela Mihailescu; Mihaela Savin; Iulia Matei
Journal:  Int J Mol Sci       Date:  2013-01-31       Impact factor: 5.923

5.  Binding Performance of Human Intravenous Immunoglobulin and 20(S)-7-Ethylcamptothecin.

Authors:  Yong-Chun Liu; Ying-Ying Li; Xiao-Jun Yao; Hui-Li Qi; Xiao-Xia Wei; Jian-Ning Liu
Journal:  Molecules       Date:  2018-09-18       Impact factor: 4.411

6.  Kaempferol, a Major Flavonoid in Ginkgo Folium, Potentiates Angiogenic Functions in Cultured Endothelial Cells by Binding to Vascular Endothelial Growth Factor.

Authors:  Wei-Hui Hu; Huai-You Wang; Yi-Teng Xia; Diana Kun Dai; Qing-Ping Xiong; Tina Ting-Xia Dong; Ran Duan; Gallant Kar-Lun Chan; Qi-Wei Qin; Karl Wah-Keung Tsim
Journal:  Front Pharmacol       Date:  2020-04-28       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.